Search results
A global labor shortage will send tech stocks soaring, with the sector poised to grow to 50% of the...
Business Insider via Yahoo Finance· 4 days agoLee made the comments shortly after Nvidia posed a blockbuster first-quarter earnings report, which...
Supreme Court dropping decisions on abortion, Trump immunity and more in coming days
USA TODAY via Yahoo News· 3 days agoWASHINGTON ā Buckle up. The Supreme Court in the coming days will issue a flurry of potentially ...
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
Motley Fool via Yahoo Finance· 18 hours agoAlthough Pfizer's stock price is down, the pharmaceutical company has steadily raised its dividend...
Nvidia Remains the Stock to Own in This Bull Market
InvestorPlace· 5 days agoNvidia stock has enjoyed multiple catalysts this year ā from blockbuster earnings and the stock split to the launch of new artificial ...
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Motley Fool via Yahoo Finance· 5 days agoAs long as the company is strong, the income will still arrive, and the stock should do well in the...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 5 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 6 days agoBy comparison, the average forward multiple among big pharma stocks is around 17 and the S&P 500...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street |...
The Motley Fool· 7 days agoSummit Therapeutics (SMMT -1.96%) is sizzling hot this year, with its shares skyrocketing around...
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 3 days agoIām mildly bullish on Regeneron, given the strength of blockbuster antibody Dupixent and the growth...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoZepbound is projected to generate $4.5 billion in sales. In 2029, analysts expect the two drugs to...